S2: #016: Harry Rowland on Touching Hearts with Implantable Technology

Today I’m talking with Harry Rowland, co-founder and CEO of Endotronix. Endotronix was founded in 2007 and is developing an implantable pressure sensor that can be placed in the pulmonary artery outside the heart. Dr. Rowland has led the company’s innovation, strategy and technology developments since the project began and has raised millions of dollars in funding. In this episode, he shares the exciting new prospects this technology offers as part of a complete health system that provides tools and feedbacks to help extend and improve patient’s lives. Today’s Topics: Dr. Rowland’s background in engineering and healthcare entrepreneurship Advanced heart failure, current standards of care and healthcare costs Endotronix implantable sensors and proactive heart disease management Raising capital for the business Perseverance and commitment as a startup Future of Endotronix and clinical testing Advice for new healthcare startups Engaging both patients and clinicians to make the product successful Links and Resources Mentioned: Digital Health Events Dan Kendall @ Twitter [email protected] Join Digital Health Today Endotronix website Endotronix Wireless Health Monitoring video Win Forever by Pete Carroll Heart Failure Society of America European Society of Cardiology – Heart Failure Association Learn more about your ad choices. Visit megaphone.fm/adchoices

There are no comments yet.

Please log in to write the first comment.